Simulations Plus, Inc. (NASDAQ: SLP) Stock Competitors & Peer Comparison
See SLP's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SLP and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SLP | $18.33 | +0.52% | 369.1M | 20.74 | $0.88 | N/A |
| VEEV | $180.02 | -4.87% | 30B | 22.15 | $8.33 | N/A |
| GEHC | $61.68 | -0.58% | 27.9B | 13.47 | $4.56 | +0.23% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSGU | $227.54 | -1.72% | 13.7B | 207.21 | $1.11 | N/A |
| BTSG | $69.02 | -4.88% | 13.7B | 56.24 | $1.24 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| TEM | $45.85 | -6.39% | 8.2B | -93.92 | -$0.50 | N/A |
| HQY | $94.87 | -2.96% | 8B | 22.42 | $4.28 | N/A |
| HNGE | $76.77 | -8.99% | 6.1B | 40.54 | $1.95 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
SLP vs VEEV Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, VEEV has a market cap of 30B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while VEEV trades at $180.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas VEEV's P/E ratio is 22.15. In terms of profitability, SLP's ROE is +0.06%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, SLP is less volatile compared to VEEV. This indicates lower risk in terms of short-term price fluctuations for SLP.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
SLP vs GEHC Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, GEHC has a market cap of 27.9B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while GEHC trades at $61.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas GEHC's P/E ratio is 13.47. In terms of profitability, SLP's ROE is +0.06%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, SLP is less volatile compared to GEHC. This indicates lower risk in terms of short-term price fluctuations for SLP.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
SLP vs GEHCV Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas GEHCV's P/E ratio is N/A. In terms of profitability, SLP's ROE is +0.06%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, SLP is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for SLP.Check GEHCV's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
SLP vs BTSGU Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, BTSGU has a market cap of 13.7B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while BTSGU trades at $227.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas BTSGU's P/E ratio is 207.21. In terms of profitability, SLP's ROE is +0.06%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, SLP is less volatile compared to BTSGU. This indicates lower risk in terms of short-term price fluctuations for SLP.Check BTSGU's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
SLP vs BTSG Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, BTSG has a market cap of 13.7B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while BTSG trades at $69.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas BTSG's P/E ratio is 56.24. In terms of profitability, SLP's ROE is +0.06%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, SLP is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for SLP.Check BTSG's competition here
Signify Health, Inc. (NYSE: SGFY)
SLP vs SGFY Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas SGFY's P/E ratio is 70.91. In terms of profitability, SLP's ROE is +0.06%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, SLP is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for SLP.Check SGFY's competition here
Tempus AI, Inc. (NASDAQ: TEM)
SLP vs TEM Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, TEM has a market cap of 8.2B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while TEM trades at $45.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas TEM's P/E ratio is -93.92. In terms of profitability, SLP's ROE is +0.06%, compared to TEM's ROE of -0.70%. Regarding short-term risk, SLP is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for SLP.Check TEM's competition here
HealthEquity, Inc. (NASDAQ: HQY)
SLP vs HQY Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, HQY has a market cap of 8B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while HQY trades at $94.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas HQY's P/E ratio is 22.42. In terms of profitability, SLP's ROE is +0.06%, compared to HQY's ROE of +0.11%. Regarding short-term risk, SLP is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for SLP.Check HQY's competition here
Hinge Health, Inc. (NYSE: HNGE)
SLP vs HNGE Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, HNGE has a market cap of 6.1B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while HNGE trades at $76.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas HNGE's P/E ratio is 40.54. In terms of profitability, SLP's ROE is +0.06%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, SLP is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for SLP.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
SLP vs RCM Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas RCM's P/E ratio is -102.21. In terms of profitability, SLP's ROE is +0.06%, compared to RCM's ROE of +0.00%. Regarding short-term risk, SLP is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for SLP.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
SLP vs TXG Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, TXG has a market cap of 6B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while TXG trades at $47.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas TXG's P/E ratio is -276.76. In terms of profitability, SLP's ROE is +0.06%, compared to TXG's ROE of -0.03%. Regarding short-term risk, SLP is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for SLP.Check TXG's competition here
Doximity, Inc. (NYSE: DOCS)
SLP vs DOCS Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, DOCS has a market cap of 3.8B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while DOCS trades at $20.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas DOCS's P/E ratio is 13.39. In terms of profitability, SLP's ROE is +0.06%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, SLP is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for SLP.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
SLP vs ONEM Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas ONEM's P/E ratio is -7.77. In terms of profitability, SLP's ROE is +0.06%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, SLP is less volatile compared to ONEM. This indicates lower risk in terms of short-term price fluctuations for SLP.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
SLP vs PRVA Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, PRVA has a market cap of 3.2B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while PRVA trades at $25.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas PRVA's P/E ratio is 158.56. In terms of profitability, SLP's ROE is +0.06%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, SLP is less volatile compared to PRVA. This indicates lower risk in terms of short-term price fluctuations for SLP.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
SLP vs PGNY Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, PGNY has a market cap of 2.5B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while PGNY trades at $31.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas PGNY's P/E ratio is 22.88. In terms of profitability, SLP's ROE is +0.06%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, SLP is less volatile compared to PGNY. This indicates lower risk in terms of short-term price fluctuations for SLP.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
SLP vs HTFL Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, HTFL has a market cap of 2.1B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while HTFL trades at $24.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas HTFL's P/E ratio is -12.05. In terms of profitability, SLP's ROE is +0.06%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, SLP is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for SLP.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
SLP vs WGS Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, WGS has a market cap of 1.9B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while WGS trades at $62.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas WGS's P/E ratio is 73.65. In terms of profitability, SLP's ROE is +0.06%, compared to WGS's ROE of -0.28%. Regarding short-term risk, SLP is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for SLP.Check WGS's competition here
Teladoc Health, Inc. (NYSE: TDOC)
SLP vs TDOC Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, TDOC has a market cap of 1.6B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while TDOC trades at $8.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas TDOC's P/E ratio is -9.90. In terms of profitability, SLP's ROE is +0.06%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, SLP is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for SLP.Check TDOC's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
SLP vs NXGN Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas NXGN's P/E ratio is -266.00. In terms of profitability, SLP's ROE is +0.06%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, SLP is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for SLP.Check NXGN's competition here
Agiliti, Inc. (NYSE: AGTI)
SLP vs AGTI Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas AGTI's P/E ratio is -71.79. In terms of profitability, SLP's ROE is +0.06%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, SLP is less volatile compared to AGTI. This indicates lower risk in terms of short-term price fluctuations for SLP.Check AGTI's competition here
Omada Health (NASDAQ: OMDA)
SLP vs OMDA Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while OMDA trades at $21.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas OMDA's P/E ratio is 328.43. In terms of profitability, SLP's ROE is +0.06%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, SLP is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for SLP.Check OMDA's competition here
Certara, Inc. (NASDAQ: CERT)
SLP vs CERT Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while CERT trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas CERT's P/E ratio is 17.67. In terms of profitability, SLP's ROE is +0.06%, compared to CERT's ROE of -0.01%. Regarding short-term risk, SLP is less volatile compared to CERT. This indicates lower risk in terms of short-term price fluctuations for SLP.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
SLP vs GDRX Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, GDRX has a market cap of 1B. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while GDRX trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas GDRX's P/E ratio is 8.88. In terms of profitability, SLP's ROE is +0.06%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, SLP is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for SLP.Check GDRX's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
SLP vs CCLDO Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas CCLDO's P/E ratio is N/A. In terms of profitability, SLP's ROE is +0.06%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, SLP is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for SLP.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
SLP vs HSTM Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, HSTM has a market cap of 785.6M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while HSTM trades at $26.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas HSTM's P/E ratio is 35.38. In terms of profitability, SLP's ROE is +0.06%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, SLP is less volatile compared to HSTM. This indicates lower risk in terms of short-term price fluctuations for SLP.Check HSTM's competition here
Evolent Health, Inc. (NYSE: EVH)
SLP vs EVH Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, EVH has a market cap of 626M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while EVH trades at $4.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas EVH's P/E ratio is 556.50. In terms of profitability, SLP's ROE is +0.06%, compared to EVH's ROE of -0.78%. Regarding short-term risk, SLP is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for SLP.Check EVH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
SLP vs MPLN-WT Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, SLP's ROE is +0.06%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, SLP is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for SLP.Check MPLN-WT's competition here
Phreesia, Inc. (NYSE: PHR)
SLP vs PHR Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, PHR has a market cap of 618.7M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while PHR trades at $9.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas PHR's P/E ratio is 35.75. In terms of profitability, SLP's ROE is +0.06%, compared to PHR's ROE of +0.03%. Regarding short-term risk, SLP is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for SLP.Check PHR's competition here
Accolade, Inc. (NASDAQ: ACCD)
SLP vs ACCD Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas ACCD's P/E ratio is -3.08. In terms of profitability, SLP's ROE is +0.06%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, SLP is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for SLP.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
SLP vs SHCR Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas SHCR's P/E ratio is -3.76. In terms of profitability, SLP's ROE is +0.06%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, SLP is less volatile compared to SHCR. This indicates lower risk in terms of short-term price fluctuations for SLP.Check SHCR's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
SLP vs WGSWW Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, WGSWW has a market cap of 514.5M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas WGSWW's P/E ratio is N/A. In terms of profitability, SLP's ROE is +0.06%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, SLP is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for SLP.Check WGSWW's competition here
NRC Health (NASDAQ: NRC)
SLP vs NRC Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, NRC has a market cap of 484.1M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while NRC trades at $20.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas NRC's P/E ratio is 26.20. In terms of profitability, SLP's ROE is +0.06%, compared to NRC's ROE of +0.57%. Regarding short-term risk, SLP is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for SLP.Check NRC's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
SLP vs SOPH Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, SOPH has a market cap of 439.9M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while SOPH trades at $6.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas SOPH's P/E ratio is -12.31. In terms of profitability, SLP's ROE is +0.06%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, SLP is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for SLP.Check SOPH's competition here
Claritev Corporation (NYSE: CTEV)
SLP vs CTEV Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, CTEV has a market cap of 425.9M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while CTEV trades at $22.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas CTEV's P/E ratio is -1.92. In terms of profitability, SLP's ROE is +0.06%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, SLP is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for SLP.Check CTEV's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
SLP vs SLGC Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas SLGC's P/E ratio is -3.04. In terms of profitability, SLP's ROE is +0.06%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, SLP is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for SLP.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
SLP vs SLGCW Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, SLP's ROE is +0.06%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, SLP is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for SLP.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
SLP vs TBRG Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas TBRG's P/E ratio is 9.37. In terms of profitability, SLP's ROE is +0.06%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, SLP is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for SLP.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
SLP vs MPLN Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas MPLN's P/E ratio is -0.23. In terms of profitability, SLP's ROE is +0.06%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, SLP is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for SLP.Check MPLN's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
SLP vs TRHC Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas TRHC's P/E ratio is -4.27. In terms of profitability, SLP's ROE is +0.06%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, SLP is less volatile compared to TRHC. This indicates lower risk in terms of short-term price fluctuations for SLP.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
SLP vs SMFR Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas SMFR's P/E ratio is N/A. In terms of profitability, SLP's ROE is +0.06%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, SLP is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for SLP.Check SMFR's competition here
So-Young International Inc. (NASDAQ: SY)
SLP vs SY Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, SY has a market cap of 242.7M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while SY trades at $1.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas SY's P/E ratio is -5.61. In terms of profitability, SLP's ROE is +0.06%, compared to SY's ROE of -0.16%. Regarding short-term risk, SLP is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for SLP.Check SY's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
SLP vs SPOK Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, SPOK has a market cap of 222.4M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while SPOK trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas SPOK's P/E ratio is 17.75. In terms of profitability, SLP's ROE is +0.06%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, SLP is less volatile compared to SPOK. This indicates lower risk in terms of short-term price fluctuations for SLP.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
SLP vs AMWL Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, AMWL has a market cap of 194.8M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while AMWL trades at $10.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas AMWL's P/E ratio is -2.25. In terms of profitability, SLP's ROE is +0.06%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, SLP is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for SLP.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
SLP vs HCAT Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, HCAT has a market cap of 150.7M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while HCAT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas HCAT's P/E ratio is 10.20. In terms of profitability, SLP's ROE is +0.06%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, SLP is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for SLP.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
SLP vs CPSI Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas CPSI's P/E ratio is -183.80. In terms of profitability, SLP's ROE is +0.06%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, SLP is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for SLP.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
SLP vs OPRX Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, OPRX has a market cap of 125M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while OPRX trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas OPRX's P/E ratio is 6.11. In terms of profitability, SLP's ROE is +0.06%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, SLP is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for SLP.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
SLP vs AUGX Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas AUGX's P/E ratio is -4.99. In terms of profitability, SLP's ROE is +0.06%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, SLP is less volatile compared to AUGX. This indicates lower risk in terms of short-term price fluctuations for SLP.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
SLP vs CCLD Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, CCLD has a market cap of 93.1M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while CCLD trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas CCLD's P/E ratio is 8.11. In terms of profitability, SLP's ROE is +0.06%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, SLP is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for SLP.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
SLP vs DH Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, DH has a market cap of 74M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while DH trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas DH's P/E ratio is 2.70. In terms of profitability, SLP's ROE is +0.06%, compared to DH's ROE of -0.67%. Regarding short-term risk, SLP is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for SLP.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
SLP vs FORA Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas FORA's P/E ratio is -24.11. In terms of profitability, SLP's ROE is +0.06%, compared to FORA's ROE of -0.17%. Regarding short-term risk, SLP is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for SLP.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
SLP vs CCLDP Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas CCLDP's P/E ratio is N/A. In terms of profitability, SLP's ROE is +0.06%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, SLP is less volatile compared to CCLDP. This indicates lower risk in terms of short-term price fluctuations for SLP.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
SLP vs ONMD Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, ONMD has a market cap of 37.2M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while ONMD trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas ONMD's P/E ratio is -4.36. In terms of profitability, SLP's ROE is +0.06%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, SLP is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for SLP.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
SLP vs SNCE Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas SNCE's P/E ratio is -0.27. In terms of profitability, SLP's ROE is +0.06%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, SLP is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for SLP.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
SLP vs AKLI Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas AKLI's P/E ratio is -0.71. In terms of profitability, SLP's ROE is +0.06%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, SLP is less volatile compared to AKLI. This indicates lower risk in terms of short-term price fluctuations for SLP.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
SLP vs SHLT Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas SHLT's P/E ratio is -3.87. In terms of profitability, SLP's ROE is +0.06%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, SLP is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for SLP.Check SHLT's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
SLP vs ONMDW Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, ONMDW has a market cap of 33.2M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas ONMDW's P/E ratio is N/A. In terms of profitability, SLP's ROE is +0.06%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, SLP is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for SLP.Check ONMDW's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
SLP vs SHCRW Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, SLP's ROE is +0.06%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, SLP is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for SLP.Check SHCRW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
SLP vs EUDA Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, EUDA has a market cap of 26.4M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while EUDA trades at $14.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas EUDA's P/E ratio is -26.64. In terms of profitability, SLP's ROE is +0.06%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, SLP is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for SLP.Check EUDA's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
SLP vs STRM Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas STRM's P/E ratio is -2.40. In terms of profitability, SLP's ROE is +0.06%, compared to STRM's ROE of -0.32%. Regarding short-term risk, SLP is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for SLP.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
SLP vs RNLX Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas RNLX's P/E ratio is -0.33. In terms of profitability, SLP's ROE is +0.06%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, SLP is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for SLP.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
SLP vs LIFW Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas LIFW's P/E ratio is -0.02. In terms of profitability, SLP's ROE is +0.06%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, SLP is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for SLP.Check LIFW's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
SLP vs BEATW Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, BEATW has a market cap of 21M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while BEATW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas BEATW's P/E ratio is -0.06. In terms of profitability, SLP's ROE is +0.06%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, SLP is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for SLP.Check BEATW's competition here
Babylon Holdings Limited (NYSE: BBLN)
SLP vs BBLN Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas BBLN's P/E ratio is -0.04. In terms of profitability, SLP's ROE is +0.06%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, SLP is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for SLP.Check BBLN's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
SLP vs ETAO Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas ETAO's P/E ratio is -0.01. In terms of profitability, SLP's ROE is +0.06%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, SLP is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for SLP.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
SLP vs BFRG Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, BFRG has a market cap of 7.4M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while BFRG trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas BFRG's P/E ratio is -1.18. In terms of profitability, SLP's ROE is +0.06%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, SLP is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for SLP.Check BFRG's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
SLP vs SCNX Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, SCNX has a market cap of 6.2M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while SCNX trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas SCNX's P/E ratio is -0.16. In terms of profitability, SLP's ROE is +0.06%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, SLP is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for SLP.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH)
SLP vs UPH Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas UPH's P/E ratio is -0.07. In terms of profitability, SLP's ROE is +0.06%, compared to UPH's ROE of -1.05%. Regarding short-term risk, SLP is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for SLP.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
SLP vs UPH-WT Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, SLP's ROE is +0.06%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, SLP is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for SLP.Check UPH-WT's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
SLP vs MGRX Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, MGRX has a market cap of 5.2M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while MGRX trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas MGRX's P/E ratio is -0.38. In terms of profitability, SLP's ROE is +0.06%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, SLP is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for SLP.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
SLP vs PEAR Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas PEAR's P/E ratio is -0.08. In terms of profitability, SLP's ROE is +0.06%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, SLP is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for SLP.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
SLP vs PEARW Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas PEARW's P/E ratio is -0.00. In terms of profitability, SLP's ROE is +0.06%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, SLP is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for SLP.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
SLP vs OTRK Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas OTRK's P/E ratio is -0.02. In terms of profitability, SLP's ROE is +0.06%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, SLP is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for SLP.Check OTRK's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
SLP vs HCTI Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, HCTI has a market cap of 2M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while HCTI trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas HCTI's P/E ratio is -0.22. In terms of profitability, SLP's ROE is +0.06%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, SLP is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for SLP.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
SLP vs CMAX Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas CMAX's P/E ratio is -0.00. In terms of profitability, SLP's ROE is +0.06%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, SLP is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for SLP.Check CMAX's competition here
Aclarion, Inc. (NASDAQ: ACON)
SLP vs ACON Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, ACON has a market cap of 1.4M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while ACON trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas ACON's P/E ratio is -0.24. In terms of profitability, SLP's ROE is +0.06%, compared to ACON's ROE of -0.54%. Regarding short-term risk, SLP is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for SLP.Check ACON's competition here
VSee Health, Inc. (NASDAQ: VSEE)
SLP vs VSEE Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, VSEE has a market cap of 1.3M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while VSEE trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas VSEE's P/E ratio is -0.15. In terms of profitability, SLP's ROE is +0.06%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, SLP is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for SLP.Check VSEE's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
SLP vs VSEEW Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, VSEEW has a market cap of 1.3M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, SLP's ROE is +0.06%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, SLP is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for SLP.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
SLP vs LIFWZ Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, SLP's ROE is +0.06%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, SLP is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for SLP.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
SLP vs EUDAW Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, SLP's ROE is +0.06%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, SLP is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for SLP.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
SLP vs WORX Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, WORX has a market cap of 610.8K. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while WORX trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas WORX's P/E ratio is -0.67. In terms of profitability, SLP's ROE is +0.06%, compared to WORX's ROE of -0.65%. Regarding short-term risk, SLP is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for SLP.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
SLP vs MSPRZ Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, SLP's ROE is +0.06%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, SLP is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for SLP.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
SLP vs KERN Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas KERN's P/E ratio is -0.01. In terms of profitability, SLP's ROE is +0.06%, compared to KERN's ROE of -0.17%. Regarding short-term risk, SLP is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for SLP.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
SLP vs KERNW Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas KERNW's P/E ratio is -0.00. In terms of profitability, SLP's ROE is +0.06%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, SLP is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for SLP.Check KERNW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
SLP vs ZCMD Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, ZCMD has a market cap of 152.1K. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while ZCMD trades at $1.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas ZCMD's P/E ratio is -0.15. In terms of profitability, SLP's ROE is +0.06%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, SLP is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for SLP.Check ZCMD's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
SLP vs LIFWW Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas LIFWW's P/E ratio is N/A. In terms of profitability, SLP's ROE is +0.06%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, SLP is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for SLP.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
SLP vs CMAXW Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas CMAXW's P/E ratio is N/A. In terms of profitability, SLP's ROE is +0.06%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, SLP is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for SLP.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
SLP vs ACONW Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, ACONW has a market cap of 11.6K. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas ACONW's P/E ratio is N/A. In terms of profitability, SLP's ROE is +0.06%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, SLP is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for SLP.Check ACONW's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
SLP vs MTBCO Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas MTBCO's P/E ratio is N/A. In terms of profitability, SLP's ROE is +0.06%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, SLP is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for SLP.Check MTBCO's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
SLP vs AFFX Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas AFFX's P/E ratio is N/A. In terms of profitability, SLP's ROE is +0.06%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, SLP is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for SLP.Check AFFX's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
SLP vs MTBCP Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas MTBCP's P/E ratio is N/A. In terms of profitability, SLP's ROE is +0.06%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, SLP is less volatile compared to MTBCP. This indicates lower risk in terms of short-term price fluctuations for SLP.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
SLP vs MTBC Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas MTBC's P/E ratio is N/A. In terms of profitability, SLP's ROE is +0.06%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, SLP is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for SLP.Check MTBC's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
SLP vs CHNG Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas CHNG's P/E ratio is -152.72. In terms of profitability, SLP's ROE is +0.06%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, SLP is less volatile compared to CHNG. This indicates lower risk in terms of short-term price fluctuations for SLP.Check CHNG's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
SLP vs CHNGU Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas CHNGU's P/E ratio is N/A. In terms of profitability, SLP's ROE is +0.06%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, SLP is less volatile compared to CHNGU. This indicates lower risk in terms of short-term price fluctuations for SLP.Check CHNGU's competition here
Cue Health Inc. (NASDAQ: HLTH)
SLP vs HLTH Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, HLTH has a market cap of 0. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while HLTH trades at $25.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas HLTH's P/E ratio is N/A. In terms of profitability, SLP's ROE is +0.06%, compared to HLTH's ROE of +0.00%. Regarding short-term risk, SLP is less volatile compared to HLTH. This indicates lower risk in terms of short-term price fluctuations for SLP.Check HLTH's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
SLP vs CNVY Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas CNVY's P/E ratio is -71.50. In terms of profitability, SLP's ROE is +0.06%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, SLP is less volatile compared to CNVY. This indicates lower risk in terms of short-term price fluctuations for SLP.Check CNVY's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
SLP vs NAVA Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas NAVA's P/E ratio is N/A. In terms of profitability, SLP's ROE is +0.06%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, SLP is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for SLP.Check NAVA's competition here
Cerner Corporation (NASDAQ: CERN)
SLP vs CERN Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, CERN has a market cap of 0. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas CERN's P/E ratio is 55.84. In terms of profitability, SLP's ROE is +0.06%, compared to CERN's ROE of +0.14%. Regarding short-term risk, SLP is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for SLP.Check CERN's competition here
Castlight Health, Inc. (NYSE: CSLT)
SLP vs CSLT Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas CSLT's P/E ratio is -37.27. In terms of profitability, SLP's ROE is +0.06%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, SLP is less volatile compared to CSLT. This indicates lower risk in terms of short-term price fluctuations for SLP.Check CSLT's competition here
NantHealth, Inc. (NASDAQ: NH)
SLP vs NH Comparison July 2026
Simulations Plus, Inc. (NASDAQ: SLP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SLP stands at 369.1M. In comparison, NH has a market cap of 0. Regarding current trading prices, SLP is priced at $18.33 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SLP currently has a P/E ratio of 20.74, whereas NH's P/E ratio is -0.12. In terms of profitability, SLP's ROE is +0.06%, compared to NH's ROE of +0.35%. Regarding short-term risk, SLP is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for SLP.Check NH's competition here